Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Pew Research Center; Chart: Kerrie Vila/Axios

Americans have mixed views on how far to take gene editing technology, favoring it in cases where it improves the health of their offspring, but opposing attempts to enhance a baby's intelligence, according to a new Pew Research Center survey out today.

Why it matters: As the science of gene editing nears the point where it's safe to use in humans, society will face a choice of how far is too far when using it. The prospect of so-called "designer babies" clearly rattles many, judging from the poll, but it's also unrealistic considering doctors' focus on using this technology to treat illnesses.

The big picture: Gene editing is the subject of intense research and is viewed as a possible route to treating or even preventing diseases ranging from cancer to sickle cell disease. It is also thought to be a potential way to tailor a baby's genetic makeup to favor particular traits.

Based on the poll of 2,537 U.S. adults conducted between April 23 and May 6, 2018 by the Pew Research Center, the public views gene editing for the purposes of tailoring their babies' traits with deep suspicion.

Between the lines: Americans with high levels of religious commitment are split 46% to 53% over whether it is appropriate to use gene editing to cut a baby's risk of developing a disease later in life. However, 73% of those with low levels of religious commitment think this is an appropriate use of medical technology.

  • A solid majority of 65% also said using human embryos to test gene editing would go too far.
  • The survey reveals a possible public relations challenge for people and companies involved in gene editing, since those surveyed tended to view a future where gene editing is more widely available as one with more negative outcomes compared to benefits.
  • 58% believe gene editing will lead to increased inequality, and 54% see it as a slippery slope, agreeing that "“even if gene editing is used appropriately in some cases, others will use these techniques in ways that are morally unacceptable.”
  • More men support gene editing to reduce the risk of developing a serious disease later in life, and also of using gene editing to treat a congenital disorder.

Where it stands: Interestingly, the public tends to doubt whether medical experts "fully comprehend the health consequences of gene editing," the survey finds. Just 36% of Americans believe that researchers understand the health effects of gene editing for babies very (7%) or fairly well (29%).

This skepticism may be well-founded, given that several recent studies have found potentially serious downsides to some gene editing methods.

Go deeper: CRISPR editing may cause more DNA damage than expected.

Go deeper

Dead malls get new life

Illustration: Aïda Amer/Axios

Malls are becoming ghosts of retail past. But the left-behind real estate is being reimagined for a post-pandemic world.

Why it matters: As many as 17% of malls in the U.S. "may no longer be viable as shopping centers and need to be redeveloped into other uses," per Barclays.

White House now says Biden will move to increase refugee cap by May 15

Photo: Chip Somodevilla/Getty Images

The White House on Friday afternoon said President Biden plans to lift the Trump-era refugee cap by May 15.

Driving the news: The announcement follows stinging criticism from several Democrats and rights groups, who said Biden was walking back on his pledge to raise the limit. Earlier Friday, Biden signed a directive to speed up the processing of refugees, but kept the Trump administration's historically low cap of 15,000 refugees for this year.